Default Fellow

John Cohrssen

Filter By:

Topic

Recent Commentary

Analysis and Commentary

How The FDA Virtually Destroyed An Entire Sector Of Biotechnology

by John Cohrssen, Henry I. Millervia Regulation (Cato Institute)
Wednesday, December 20, 2017

Dogs bark, cows moo, and regulators regulate,” former U.S. Food and Drug Administration commissioner Frank Young once quipped to explain regulatory agencies’ expansionist tendencies. There may be no better example than the FDA’s oversight of genetically engineered animals.

Analysis and Commentary

Solve US Drug Shortages With Imported Medicine That Measures Up To FDA Standards

by John Cohrssen, Henry I. Millervia The Hill
Thursday, November 30, 2017

Occasionally we encounter a simple tweak in public policy that would be a win-win -— if it weren’t for politicians, bureaucrats and stakeholders zealously guarding their self-interest. An example is a reform that would both help combat shortages of critical drugs and put downward pressure on prices: reciprocity of drug approvals between FDA and certain foreign counterparts.

Analysis and Commentary

Current FDA Approach To Genetically Engineered Animals Is Flawed

by John Cohrssen, Henry I. Millervia The Hill
Monday, November 6, 2017

Contrary to Article I of the U.S. Constitution, which vests all legislative power in the Congress, federal agencies can expand their jurisdiction by forcefully pushing policy initiatives into regulatory regimes for which they were never intended.

Analysis and Commentary

Dysfunctional Federal Regulation Has Worsened The Post-Hurricane Mosquito Threat

by John Cohrssen, Henry I. Millervia The Hill
Thursday, September 21, 2017

In the aftermath of the devastation of buildings and infrastructure and the toxic marinade of floodwaters by Hurricanes Harvey and Irma, Mother Nature is literally hatching another hazard: disease-carrying mosquitoes that will find new breeding grounds in the innumerable pools of standing water from torrential rains and storm surges.

Analysis and Commentary

FDA Is The Wrong Agency To Regulate Genetically Engineered Animals

by John Cohrssen, Henry I. Millervia Nature
Wednesday, July 12, 2017

As individuals who spent years in US government positions (H.I.M. is a former special assistant to the US Food and Drug Administration (FDA) commissioner and founding director of the FDA's Office of Biotechnology; J.J.C. is former counsel to both the White House Biotechnology Working Group and the House Energy and Commerce Committee as well as former Senior Associate of the President's Advisory Council on Executive Organization), we know how important 'location, location, location' is for regulatory jurisdiction.

an image
Featured

To Modulate Drug Prices, We Need Less Regulation And More Competition

by Henry I. Miller, John Cohrssenvia National Review
Wednesday, January 25, 2017

Allowing drugs in the U.S. that have been approved abroad would greatly help patients, providers, and producers. 

Analysis and Commentary

The FDA’s Dr. Nos

by John Cohrssen, Henry I. Millervia Regulation (Cato Institute)
Thursday, January 5, 2017

The agency’s fear of Type II errors inhibits drug development and harms patients.

Featured

Drain The Regulatory Swamp, Let Agriculture Bloom

by John Cohrssen, Henry I. Millervia Forbes
Wednesday, December 7, 2016

Worries about slow economic growth have shifted the mood of America from “hope and change” eight years ago to “drain the swamp,” which is at least in part a realization that government regulation needs major fixes to spur innovation and job creation.

Analysis and Commentary

FDA's Demands And Delays Harm Desperate Patients

by Henry I. Miller, John Cohrssenvia Forbes
Wednesday, October 19, 2016

Regulators sometimes respond positively to public pressure. During the height of the AIDS epidemic of the 1980’s, for example, the Food and Drug Administration came under fire and its headquarters was literally stormed by AIDS activists protesting regulators’ unwillingness to make new investigational drugs available to patients who had no alternative treatment.

Analysis and Commentary

Why Are The Feds Blocking Technologies To Control The Mosquitoes That Spread Zika Virus?

by John Cohrssen, Henry I. Millervia Forbes
Wednesday, September 7, 2016

Zika virus infections, which in recent months have swept through South and Central America and the Caribbean, are typically mild and often go undetected, but infection can cause severe birth defects early in pregnancy and subtler ones later. It can also cause a progressive, usually temporary, paralysis called Guillain-Barré syndrome. 

Pages